12 Health Care Stocks Moving In Friday's Intraday Session
Portfolio Pulse from Benzinga Insights
During Friday's intraday session, several healthcare stocks experienced significant movements. Ainos (AIMD) led the gainers with a 74.0% increase, while Mesoblast (MESO) saw the largest decline among the losers, dropping 50.0%. Other notable gainers include Elevation Oncology (ELEV), Alaunos Therapeutics (TCRT), Axogen (AXGN), NexImmune (NEXI), and Inovio Pharmaceuticals (INO). On the losing side, Applied Therapeutics (APLT), Avenue Therapeutics (ATXI), Inspire Veterinary (IVP), Agilon Health (AGL), and Omega Therapeutics (OMGA) also saw significant drops in their stock prices.

January 05, 2024 | 5:31 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Agilon Health stock decreased by 32.99% to $8.1, with a market cap of $3.2 billion.
Agilon Health's significant stock price drop could reflect underlying issues or market reactions, potentially leading to more short-term downside.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Applied Therapeutics stock decreased by 36.94% to $2.39, with a market cap of $184.5 million.
The significant decline in Applied Therapeutics' stock price suggests negative market sentiment, which could persist in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Mesoblast shares fell by 50.0% to $1.04, with a market cap of $178.4 million.
The drastic drop in Mesoblast's stock price could indicate significant negative sentiment, likely leading to further short-term declines.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Ainos stock surged by 74.0% to $3.01, with a market cap of $14.0 million.
The substantial surge in Ainos' stock price indicates strong investor interest, which could lead to continued short-term momentum.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Elevation Oncology stock increased by 43.29% to $0.85, with a market cap of $35.9 million.
Elevation Oncology's significant price increase reflects investor optimism, potentially leading to further short-term appreciation.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100